These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Comparison of whole-body PET/CT, dedicated high-resolution head and neck PET/CT, and contrast-enhanced CT in preoperative staging of clinically M0 squamous cell carcinoma of the head and neck. Rodrigues RS; Bozza FA; Christian PE; Hoffman JM; Butterfield RI; Christensen CR; Heilbrun M; Wiggins RH; Hunt JP; Bentz BG; Hitchcock YJ; Morton KA J Nucl Med; 2009 Aug; 50(8):1205-13. PubMed ID: 19617339 [TBL] [Abstract][Full Text] [Related]
29. Detection of hepatic metastases: comparison of contrast-enhanced CT, unenhanced MR imaging, and iron oxide-enhanced MR imaging. Fretz CJ; Stark DD; Metz CE; Elizondo G; Weissleder R; Shen JH; Wittenberg J; Simeone J; Ferrucci JT AJR Am J Roentgenol; 1990 Oct; 155(4):763-70. PubMed ID: 2119106 [TBL] [Abstract][Full Text] [Related]
30. Comparison of MRI (including SS SE-EPI and SPIO-enhanced MRI) and FDG-PET/CT for the detection of colorectal liver metastases. Coenegrachts K; De Geeter F; ter Beek L; Walgraeve N; Bipat S; Stoker J; Rigauts H Eur Radiol; 2009 Feb; 19(2):370-9. PubMed ID: 18795299 [TBL] [Abstract][Full Text] [Related]
31. Detection of colorectal metastases in patients being treated with chemotherapy utilising SPIO-MRI: a radiological-pathological study. Smith JT; Ward J; Guthrie JA; Sheridan MB; Boyes S; Wilson D; Wyatt JI; Treanor D; Robinson PJ Magn Reson Imaging; 2012 Dec; 30(10):1446-53. PubMed ID: 22898686 [TBL] [Abstract][Full Text] [Related]
32. The clinical impact of magnetic resonance imaging in diagnosing focal hepatic lesions and suspected cancer. Shah AJ; Parsons B; Pope I; Callaway M; Finch-Jones MD; Thomas MG Clin Imaging; 2009; 33(3):209-12. PubMed ID: 19411027 [TBL] [Abstract][Full Text] [Related]
33. Detection of liver metastasis: modality of choice? Rasmussen F Acta Radiol; 2007 May; 48(4):361. PubMed ID: 17453512 [No Abstract] [Full Text] [Related]
34. Hepatic metastases: use of diffusion-weighted echo-planar imaging. Bruegel M; Rummeny EJ Abdom Imaging; 2010 Aug; 35(4):454-61. PubMed ID: 19471997 [TBL] [Abstract][Full Text] [Related]
35. Impact of whole-body imaging on treatment decision to radio-frequency ablation in patients with malignant liver tumors: comparison of [18F]fluorodeoxyglucose-PET/computed tomography, PET and computed tomography. Kuehl H; Rosenbaum-Krumme S; Veit-Haibach P; Stergar H; Forsting M; Bockisch A; Antoch G Nucl Med Commun; 2008 Jul; 29(7):599-606. PubMed ID: 18528181 [TBL] [Abstract][Full Text] [Related]
36. Diagnostic imaging of colorectal liver metastases with CT, MR imaging, FDG PET, and/or FDG PET/CT: a meta-analysis of prospective studies including patients who have not previously undergone treatment. Niekel MC; Bipat S; Stoker J Radiology; 2010 Dec; 257(3):674-84. PubMed ID: 20829538 [TBL] [Abstract][Full Text] [Related]
37. Small colorectal liver metastases: detection with SPIO-enhanced MRI in comparison with gadobenate dimeglumine-enhanced MRI and CT imaging. Hekimoglu K; Ustundag Y; Dusak A; Kalaycioglu B; Besir H; Engin H; Erdem O Eur J Radiol; 2011 Mar; 77(3):468-72. PubMed ID: 19781882 [TBL] [Abstract][Full Text] [Related]
38. Computed tomography, magnetic resonance imaging and 11C-metomidate positron emission tomography for evaluation of adrenal incidentalomas. Hennings J; Hellman P; Ahlström H; Sundin A Eur J Radiol; 2009 Feb; 69(2):314-23. PubMed ID: 18082990 [TBL] [Abstract][Full Text] [Related]